Success Story: Postdoc's NIW Approved in 26 Days! Another Success Story with Premium Processing Service
Client’s Testimonial:
“I am incredibly grateful to Chen Immigration for their outstanding support and expertise in handling my EB2-NIW petition. From the beginning, their team demonstrated exceptional professionalism, deep knowledge of immigration law, and a highly strategic approach to case preparation. They meticulously analyzed my research, ensuring that my petition effectively highlighted its national importance. Their attention to detail, strong legal arguments, and prompt responses to all my questions made the entire process smooth and stress-free. Thanks to their expertise, my I-140 NIW petition was approved, and I couldn’t be more pleased with their service. I highly recommend Chen Immigration. They are truly the best in the field! Thank you again for your excellent service!”
On February 5th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Researcher in the Field of Biotechnology (Approval Notice).
General Field: Biotechnology
Position at the Time of Case Filing: Postdoctoral Researcher
State of Residence at the Time of Filing: Texas
Approval Notice Date: February 5th, 2025
Processing Time: 26 days (Premium Processing Requested)
Case Summary:
We are pleased to share the approval of an I-140 National Interest Waiver (NIW) petition for a highly accomplished Ph.D. holder in biology and health, infectious diseases. The petition was approved in February 2025, less than one month after its filing, recognizing the petitioner’s nationally significant research in biotechnology and public health.
Advancing U.S. Biodefense Through Pathogenic Virus Research
The petitioner’s work explores the complex biology of pathogenic viruses, including replication mechanisms, viral–host interactions, and immune evasion strategies, with a particular focus on addressing emerging outbreaks. His research has been instrumental in illuminating how viruses manipulate host cellular processes and aims to facilitate the development of advanced vaccine platforms and targeted antiviral therapies. These innovations serve not only to improve healthcare outcomes but also to strengthen the nation’s defense against viral epidemics and bioterrorism threats.
Currently engaged in biotechnology research at a U.S. academic institution, the petitioner continues to investigate the molecular dynamics of viral replication and pathogenesis using model viral systems.
Recognized Expertise and Scientific Impact
The NIW petition was bolstered by an impressive record of academic achievement and measurable contributions to the field:
- 11 peer-reviewed journal articles, plus 1 preprint;
- 177 citations to his published work;
- 11 peer reviews for respected scientific journals.
Several of his publications have ranked among the top 10% most cited in the microbiology field for their year of publication. His findings have been adopted by global researchers studying viral pathogenesis, viral-host metabolic interactions, and the broader implications of pathogenic viral evolution.
Demonstrated National Importance
The petition presented detailed evidence of the national significance of his research, which aligns with critical and emerging technology priorities outlined by the National Science and Technology Council. In particular, the petitioner’s work contributes to vital public health goals, such as mitigating bioterrorism risks, enhancing epidemic preparedness, and enabling next-generation vaccine development, domains central to U.S. security and global health leadership.
A Strong Case for Continued Scientific Contributions
Through rigorous documentation of peer-reviewed scholarship, citation impact, peer review service, and strategic alignment with U.S. public health priorities, we established the petitioner’s eligibility for a National Interest Waiver. His ongoing research will continue to shape biodefense strategy, viral immunology, and vaccine innovation in the years ahead. We are proud to have supported his success.